Stocks
Anika Therapeutics (ANIK) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2023 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.50 | -2.72 | 3.91 | -9.83 | 6.25 | 2.31 | |||
| Changes by years, y/y, % | -182% | -209% | -244% | -352% | -164% | -45.2% | |||
Anika Therapeutics. Debt/EBITDA
Anika Therapeutics. Debt/EBITDA, changes, %
Anika Therapeutics (ANIK) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 20.9 | 6.61 | -1.73 | 6.35 | 2.31 | 2.31 | ||
| Changes by years, y/y, % | +113% | -28% | -225% | -89% | -89% | |||
| Changes by quarters, q/q, % | -64% | -68% | -126% | -467% | -64% | |||
